JESSICA SANCHEZ, NP
Ambulatory Care Registered Nurse in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JESSICA SANCHEZ, NP reported a CMS MIPS final score of 34.5839/100 — below the 83.1 national average — and filed 1,753 Medicare Part D claims in 2023.
- 34.5839/100
- MIPS score · -49 vs avg
- 2K
- Part D claims, 2023
- $272.48
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JESSICA SANCHEZ, NP's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
35 3rd percentile higher than 3% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about JESSICA SANCHEZ, NP?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Ambulatory Care Registered Nurse compares to other specialties among California providers
Ambulatory Care Registered Nurse share within California
Ambulatory Care Registered Nurse is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
JESSICA SANCHEZ, NP's 2023 MIPS final score plotted against the Ambulatory Care Registered Nurse national average
- MIPS Final Score
- 34.5839/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ambulatory Care Registered Nurse) — 34.5839/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Ambulatory Care Registered Nurse US NPIs
34.5839/100 MIPS final score — 48.5 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ambulatory Care Registered Nurse. Quality dim: 15.4303. Cost dim: 63.0993.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JESSICA SANCHEZ, NP appears in the CMS NPPES registry as a Ambulatory Care Registered Nurse provider holding NP credentials at 8631 W 3RD ST STE 635E, LOS ANGELES, CA, 90048, with a listed phone of (310) 248-8245. NPI 1588235139 was issued on 07/06/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SANCHEZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,753 prescription claims written by this provider, covering 471 Medicare beneficiaries and totaling roughly $441K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 34.5839/100 for the 2023 performance year (Quality 15.4303, Cost 63.0993), compared with the national average of 83.1.
Ambulatory Care Registered Nurse is a narrow specialty nationwide, with 3,123 enrolled providers across 53 states and an average of 695 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1588235139 |
|---|---|
| Specialty | Ambulatory Care Registered Nurse |
| Credentials | NP |
| Gender | Female |
| NPI Issued | 07/06/2021 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JESSICA SANCHEZ, NP's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JESSICA SANCHEZ, NP. Source: openpaymentsdata.cms.gov.
Total received
$272
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JESSICA SANCHEZ, NP. To verify JESSICA SANCHEZ, NP's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,187
- Total Day Supply
- 124,871
- Generic Drug Cost
- $43K
Patient Demographics
- Average Patient Age
- 76.4 years
- Avg HCC Risk Score
- 1.54
- Gender Split
- 46% female / 54% male
- Age Distribution
- <65: 15, 65-74: 185, 75-84: 200, 85+: 71
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JESSICA SANCHEZ, NP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Rosuvastatin Calcium
Rosuvastatin Calcium
199 claims
- Amlodipine Besylate
Amlodipine Besylate
127 claims
- Carvedilol
Carvedilol
126 claims
- Telmisartan
Telmisartan
90 claims
- Atorvastatin Calcium
Atorvastatin Calcium
87 claims
- Eliquis 74
Eliquis
74 claims
- Metoprolol Succinate 72
Metoprolol Succinate
72 claims
- Furosemide 56
Furosemide
56 claims
| Drug | Claims |
|---|---|
| Rosuvastatin Calcium | 199 |
| Amlodipine Besylate | 127 |
| Carvedilol | 126 |
| Telmisartan | 90 |
| Atorvastatin Calcium | 87 |
| Eliquis Apixaban | 74 |
| Metoprolol Succinate | 72 |
| Furosemide | 56 |
| Irbesartan | 53 |
| Losartan Potassium | 51 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ambulatory Care Registered Nurse Overview
How JESSICA SANCHEZ, NP fits within the Ambulatory Care Registered Nurse landscape nationally.
JESSICA SANCHEZ, NP's 1,753 claims are above the specialty average of 695.
Nearby Ambulatory Care Registered Nurse Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as SANCHEZ.
Compare Ambulatory Care Registered Nurse nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is JESSICA SANCHEZ, NP's specialty? ▼
How much does JESSICA SANCHEZ, NP prescribe under Medicare Part D? ▼
What is JESSICA SANCHEZ, NP's Medicare quality score? ▼
Where is JESSICA SANCHEZ, NP located? ▼
What is JESSICA SANCHEZ, NP's NPI number? ▼
How many Ambulatory Care Registered Nurse providers are there in the US? ▼
What drugs does JESSICA SANCHEZ, NP prescribe most often? ▼
Does JESSICA SANCHEZ, NP accept Medicare? ▼
How can I verify JESSICA SANCHEZ, NP's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology